Will Bombardier Survive the Pandemic?

Bombardier trades near an all-time low. Is the stock now heavily oversold or destined to disappear due to the impact of the pandemic?

| More on:
Coronavirus 2019-nCoV Blood Samples Medical Concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Bombardier (TSX:BBD.B) faces serious challenges today. Should investors buy Bombardier stock on the hopes of a rebound?

Bombardier stock chart

A quick look a Bombardier’s stock chart over the past 20 years provides a good indication of how the company fared in its battles to be a leader in the global rail and jet industries. In October 2000, Bombardier traded for more than $25 per share. Today, the stock sells for a mere 32 cents.

Savvy traders made some good money along the way. Buy-and-hold investors, unfortunately, have mostly lost their shirts.

Contrarian investors might be tempted to see the stock as oversold and jump in at this point on the hopes of another upswing, but caution is warranted.

Assets sales

Bombardier spent the past couple of years selling off most of its operations to reduce its debt load. The process began with the sale of the troubled CSeries jet program to Airbus. Bombardier hoped the new planes would give it an edge in the mid-sized commercial plane segment, but long development and production delays resulted in the program going billions of dollars over budget.

Customer enthusiasm for the new fuel-efficient jets was high when oil traded at US$100 per barrel. Orders initially rolled in at a good clip, but Bombardier missed an opportunity to capitalize due to the delays.

In the end, the company took on heavy debt and required capital infusions from Quebec and the province’s pension fund. In early 2016, the stock dropped below $1 per share, as the market anticipated a possible bankruptcy filing. Bombardier changed management, shelved the dividend, and secured two large CSeries orders at heavily discounted prices to avoid going bust.

This gave the company some breathing room, and the shares actually topped $5 in the summer of 2018 shortly after a 50.1% interest in the CSeries officially moved to Airbus.

The good times didn’t last very long. Demand for the jets, renamed A220, didn’t fly in as expected under the Airbus umbrella. Faced with ongoing debt challenges, Bombardier eventually sold the rest of the stake to the European giant. Bombardier also sold its Dash-8 and CRJ plane divisions, finalizing the exit from the commercial airline sector.

Last month, Bombardier reached an agreement to sell the troubled rail division. The sale to Alstom is expected to close in 2021. Once that happens, Bombardier’s only remaining operations will be the business jets.

Will business jets save the company?

A second wave of the pandemic threatens to extend global travel restrictions and put additional pressure on the global economy. The E.U. just revoked permission for Canadians to travel to the region. Canada isn’t allowing any visitors to the country, and the border with the United States remains closed to all non-essential travel.

Companies might not be willing to spend on new business jets for some time. In fact, the success of virtual meetings through video platforms over the past seven months could permanently impact business travel trends.

Wealthy individuals might decide to buy their own private jets to avoid COVID-19 risks on commercial flights, but they won’t make the purchases until they are allowed to visit other countries.

For the moment, the outlook remains bleak.

Should you buy Bombardier stock now?

Buy-and-hold investors should search for other opportunities. Trades might also want to stay on the sidelines. Headwinds are pretty strong right now, so I would avoid Bombardier stock.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Walker has no position in any stock mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »